Clinical Trials Logo

Clinical Trial Summary

The objective of the study is to investigate the impact of daily consumption of MSPrebiotic at a dosage level of 30 g per day for 12 weeks on gastrointestinal microbiota in the elderly (> 70 years age) and another age group (30 to 50 years). In addition, impact of MSPrebiotic on short chain fatty acids, glucose and insulin levels as well as metabolomic changes will also be studied. A randomized, double-blinded study will be conducted to assess the health benefits of MSPrebiotic and compared with a placebo. This study will provide substantiation for a beneficial effect of MSPrebiotic resistant starch on gut microbiome.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03910153
Study type Interventional
Source Manitoba Starch Products
Contact
Status Completed
Phase N/A
Start date April 8, 2019
Completion date October 7, 2019

See also
  Status Clinical Trial Phase
Completed NCT03957239 - The Effect of a Cranberry Beverage on Intestinal Permeability and Gastrointestinal Function in Generally Healthy Adults N/A
Not yet recruiting NCT01428999 - Effects of Probiotics on Improving the Gastrointestinal Function and Intestinal Bacterial Flora N/A
Recruiting NCT06368713 - Exercise Improves Gastrointestinal Function in Peritoneal Dialysis Patients N/A
Recruiting NCT03291574 - Perioperative Electroacupuncture for Gastric Cancer Patients After Gastrectomy N/A
Recruiting NCT06254716 - A Study on the Prognosis of Two Different Surgery Methods in Patients With Rectal Endometriosis
Recruiting NCT01542970 - Can Supplementation With Lactobacillus Reuteri and Omega-3 Fatty Acids During Pregnancy and Lactation Reduce the Risk of Allergic Disease in Infancy? N/A
Recruiting NCT03291561 - Perioperative Electroacupuncture After Operation N/A